0
Correspondence |

NRAS-Mutant Melanoma: Response to Chemotherapy

Christopher W. M. Soon, MD; Alain P. Algazi, MD; Edward N. Cha, MD, PhD; Emma M. Webb, MD; Adil I. Daud, MD
Arch Dermatol. 2011;147(5):626-627. doi:10.1001/archdermatol.2011.85.
Text Size: A A A
Published online

Extract

Middleton  MRGrob  JJAaronson  N  et al.  Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000;18 (1) 158- 166
PubMed
Chapman  PBEinhorn  LHMeyers  ML  et al.  Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma. J Clin Oncol 1999;17 (9) 2745- 2751
PubMed
Devitt  BALiu  WSalemi  R  et al.  Clinical outcome and pathologic features associated with NRAS mutation in cutaneous melanoma. J Clin Oncol 2010;28 ((suppl, abstr 8500)) 15s
Davies  MAStemke-Hale  KLin  E  et al.  Integrated molecular and clinical analysis of AKT activation in metastatic melanoma. Clin Cancer Res 2009;15 (24) 7538- 7546
PubMed
Cheng  JQLindsley  CWCheng  GZYang  HNicosia  SV The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene 2005;24 (50) 7482- 7492
PubMed

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
brightcove.createExperiences();